Angiotensin II human acetate NEW
| Price | $32 | $53 | $118 |
| Package | 5mg | 10mg | 25mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-12-03 |
Product Details
| Product Name: Angiotensin II human acetate | CAS No.: 68521-88-0 |
| Purity: 99.78% | Supply Ability: 10g |
| Release date: 2025/12/03 |
Product Introduction
Bioactivity
| Name | Angiotensin II human acetate |
| Description | Angiotensin II human acetate is a key vasoconstrictor peptide in the renin-angiotensin system. It regulates blood pressure by binding to AT1R and AT2R receptors, stimulates the sympathetic nervous system, promotes aldosterone synthesis and renal function, induces vascular smooth muscle cell proliferation and collagen synthesis, leading to vascular and myocardial hypertrophy and fibrosis, while also promoting apoptosis and endothelial capillary formation. It is commonly used to induce hypertension and cardiac hypertrophy models. |
| Storage | keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : Insoluble H2O : 20 mg/mL (18.08 mM), Sonication is recommended. |
| Keywords | Inhibitor | inhibit | DRVYIHPF Acetate | DRVYIHPF | Apoptosis | Angiotensin Receptor | Angiotensin II human acetate | Angiotensin II human Acetate | Angiotensin II human | Angiotensin II Acetate | Angiotensin II | angiotensin AT1 receptor | Ang II Acetate | Ang II |
| Inhibitors Related | Stavudine | 5-Fluorouracil | Flubendazole | Cysteamine hydrochloride | Sodium 4-phenylbutyrate | L-Ascorbic acid | L-Glutamic acid | Tributyrin | L-Ascorbic acid sodium salt | Alginic acid | Dextran sulfate sodium salt (MW 5000) | Captopril |
| Related Compound Libraries | Apoptosis Compound Library | FDA-Approved & Pharmacopeia Drug Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Peptide Compound Library | Drug Repurposing Compound Library | NO PAINS Compound Library | Anti-Cancer Approved Drug Library | FDA-Approved Drug Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $0.00/10KG |
VIP2Y
|
Shandong Hanjiang Chemical Co., Ltd
|
2025-10-07 | |
| $0.00/1Box |
Shanghai Affida new material science and technology center
|
2024-04-26 | ||
| $1.00/1g |
VIP5Y
|
RongNa Biotechnology Co.,Ltd
|
2024-03-26 | |
| $10.00/1kg |
Shijiazhuang Saixin Technology Co., Ltd.
|
2023-09-12 | ||
| $35.00/1kg |
Hebei Xinsheng New Material Technology Co., LTD.
|
2023-08-23 | ||
| $50.00/1kg |
Anhui Ruihan Technology Co., Ltd
|
2023-08-22 | ||
| $30.00/1000g |
Wuhan Aoliqisi New Material Technology Co., Ltd.
|
2021-07-12 | ||
| $7.00/1KG |
VIP6Y
|
Career Henan Chemical Co
|
2020-02-18 | |
| $0.00/10KG |
VIP2Y
|
Shandong Hanjiang Chemical Co., Ltd
|
2025-10-02 | |
| $0.00/1kg |
Hebei Xinsheng New Material Technology Co., LTD.
|
2023-08-21 |
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY

United States